MD-PhD.
Graduate degree in Cardiology, (University of Buenos Aires), Clinical Investigation and Biostatistics (Argentine Medical Association), and Advanced Heart Failure/cardiomyopathies/pulmonary hypertension (Duke, UCA, Cleveland Clinic).
Professor, pharmacology department, University of Buenos Aires. Argentina.
2 books and >50 published papers in refereed journals and book chapters; >300 lectures & abstacts in CV congresses.
WHF emerging leaders program, 2018 cohort; director of SIAC´s emerging leaders program.
Research areas: Thrombosis, Antithrombotics, Atrial Fibrillation, Lipids/LLTs, Obesity and CVD, cardiometabolism, Heart Failure, Pulmonary Hypertension, Pulmonary Embolism, Chagas Disease, CV Pharmacology, Antiarrhythmics-QTc, Influenza, Covid-19 and CVDisease.
I have been working on the relation of infectious diseases and the heart, including influenza vaccine guidelines, neglected tropical diseases and the heart (NTD heart project), Chagas disease roadmap, Chagas and COVID-19, both at interamerican society of cardiology (SIAC) and WHF.
I´m based in Buenos Aires, Argentina, and currently also working at Arg Society of Cardiology (SAC) on cardiometabolic health, and as medical advisor in CV drugs development.